Skip to main content
. 2023 Jul 9;9(3):e001331. doi: 10.1136/bmjsem-2022-001331

Table 1.

Patient characteristics and medications at baseline

HIT (n=29) Standard care (n=37) P
Characteristic
 Age of donor, years 29 (22 to 46) 34 (29 to 48) 0.25
 Sex of donor, male 19 (66) 26 (70) 0.68
 Cold ischaemic time, min 205 (92 to 235) 214 (95 to 245) 0.56
 Age of recipient, years 52 (42 to 58) 52 (40 to 57) 0.90
 Sex of recipient, male 20 (69) 27 (73) 0.72
 LVAD 4 (14) 6 (16) 0.79
Reason for transplantation 0.22
 DCM 14 (48) 14 (38)
 ICM 9 (31) 8 (22)
 Other 6 (21) 15 (41)
Immunosuppressant
 Cyclosporine 20 (69) 28 (76) 0.54
 Tacrolimus 9 (31) 9 (24) 0.54
 Everolimus 10 (34) 11 (30) 0.68
 Mycophenolate 26 (90) 33 (89) 1.00
 Prednisolone 29 (100) 37 (100) 1.00
Medication at baseline
 Antiplatelet agents 4 (14) 4 (11) 0.72
 Anticoagulation 4 (14) 2 (5) 0.39
 Beta-blockers 8 (28) 11 (30) 0.85
 ACE inhibitors 0 (0) 1 (3) 1.00
 Angiotensin-receptor blockers 2 (7) 1 (3) 0.58
 Statins 28 (97) 37 (100) 0.44
 Diuretics 25 (86) 31 (84) 1.00

Data are n (%), median (IQR), or mean±SD values. p values are for between-groups comparisons at baseline.

ACE, angiotensin-converting enzyme; DCM, dilated cardiomyopathy; HIT, high-intensity interval training; ICM, ischaemic cardiomyopathy; LVAD, left ventricular assist device.